Elemental and semi-elemental formulas: Are they superior to polymeric formulas?

Practical Gastroenterology

Volumn 29, Issue 12, 2005, Pages

  Makola, Diklar ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRAQ; ELEMENT; ENTERIC FEEDING SOLUTION; FIBERSOURCE; INFUSION FLUID; ISOCAL; ISOSOURCE; JEVITY; NOVASOURCE; NUTREN; OPTIMENTAL; OSMOLITE; PEPTAMEN; PEPTINEX; PERATIVE; POLYMER; PROBALANCE; PROMOTE; REPLETE; SUBDUE; TOLEREX; TWOCAL HN; UNCLASSIFIED DRUG; VITAL; VIVONEX;

ACUTE PANCREATITIS; CHYLE; CROHN DISEASE; CYSTIC FIBROSIS; DISEASE SPECIFIC FORMULA FEEDING; DRUG FORMULATION; ELEMENTAL FORMULA FEEDING; ENTERIC FEEDING; ENTEROPATHY; GASTROENTEROLOGICAL PROCEDURES; GASTROINTESTINAL DISEASE; HUMAN; HYPOALBUMINEMIA; IMMUNE ENHANCING FORMULA FEEDING; MALABSORPTION; NUTRITIONAL SUPPORT; REVIEW; SEMI ELEMENTAL FORMULA FEEDING; SHORT BOWEL SYNDROME; TREATMENT INDICATION;

EID: 30744464372     PISSN: 02774208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Marik PE, Zaloga GP. Meta-analysis of parenteral nutrition versus enteral nutrition in patients with acute pancreatitis. BMJ, 2004;328(7453):1407.
2. Abou-Assi S, Craig K, O'Keefe SJ. Hypocaloric jejunal feeding is better than total parenteral nutrition in acute pancreatitis: results of a randomized comparative study. Am J Gastroenterol, 2002; 97(9):2255-2262.
3. Chen QP. Enteral nutrition and acute pancreatitis. World J Gastroenterol, 2001;7(2):185-192.
4. Erskine JM, Lingard CD, Sontag MK, et al. Enteral nutrition for patients with cystic fibrosis: comparison of a semi-elemental and nonelemental formula. J Pediatr, 1998;132(2):265-269.
5. Klein S Rubin D, C. Enteral and parenteral nutrition. In: Feldman M, Friedman LS, Sleisenger MH, Eds. Sleisenger & Fordtran's gastrointestinal and liver disease: pathophysiology, diagnosis, management. 7th ed. Philadelphia: Saunders; 2002:2 v. (xli, 2385, 98).
6. Farrell JJ. Digestion and absorption of nutrients and vitamins. In: Feldman M, Friedman LS, Sleisenger MH, Eds. Sleisenger & Fordtran's gastrointestinal and liver disease: pathophysiology, diagnosis, management. 7th ed. Philadelphia: Saunders; 2002:2 v. (xli, 2385, 98).
7. Silk DB, Fairclough PD, Clark ML, et al. Use of a peptide rather than free amino acid nitrogen source in chemically defined "elemental" diets. JPEN J Parenter Enteral Nutr 1980;4(6):548-553.
8. Ford EG, Hull SF, Jennings LM, et al. Clinical comparison of tolerance to elemental or polymeric enteral feedings in the postoperative patient. J Am Coll Nutr, 1992;11(1):11-16.
9. McIntyre PB, Fitchew M, Lennard-Jones JE. Patients with a high jejunostomy do not need a special diet. Gastroenterology, 1986;91(1):25-33.
10. Steinhardt HJ, Wolf A, Jakober B, et al. Nitrogen absorption in pancreatectomized patients: protein versus protein hydrolysate as substrate. J Lab Clin Med, 1989;113(2):162-167.
11. Cosnes J, Evard D, Beaugerie L, et al. Improvement in protein absorption with a small-peptide-based diet in patients with high jejunostomy. Nutrition, 1992;8(6):406-411.
12. Romano TJ, Dobbins JW. Evaluation of the patient with suspected malabsorption. Gastroenterol Clin North Am, 1989;18(3): 467-483.
13. Silk DB, Grimble GK. Relevance of physiology of nutrient absorption to formulation of enteral diets. Nutrition, 1992;8(1):1-12.
14. Hogenauer C, Hammer HF. Maldigestion and malabsorption. In: Feldman M, Friedman LS, Sleisenger MH, Eds. Sleisenger & Fordtran's gastrointestinal and liver disease: pathophysiology, diagnosis, management. 7th ed. Philadelphia: Saunders; 2002:2 v. (xli, 2385, 98).
15. Jones BJ, Lees R, Andrews J, et al. Comparison of an elemental and polymeric enteral diet in patients with normal gastrointestinal function. Gut, 1983;24(1):78-84.
16. Rees RG, Hare WR, Grimble GK, et al. Do patients with moderately impaired gastrointestinal function requiring enteral nutrition need a predigested nitrogen source? A prospective crossover controlled clinical trial. Gut, 1992;33(7):877-881.
17. Dietscher JE, Foulks CJ, Smith RW. Nutritional response of patients in an intensive care unit to an elemental formula vs a standard enteral formula. J Am Diet Assoc, 1998;98(3):335-336.
18. Ksiazyk J, Piena M, Kierkus J, et al. Hydrolyzed versus nonhydrolyzed protein diet in short bowel syndrome in children. J Pediatr Gastroenterol Nutr, 2002;35(5):615-618.
19. Klein S, Jeejeebhoy KN. The malnourished patient: nutritional assessment and management. In: Feldman M, Friedman LS, Sleisenger MH, Eds. Sleisenger & Fordtran's gastrointestinal and liver disease: pathophysiology, diagnosis, management. 7th ed. Philadelphia: Saunders; 2002:2 v. (xli, 2385, 98).
20. Brinson RR, Kolts BE. Diarrhea associated with severe hypoalbuminemia: a comparison of a peptide-based chemically defined diet and standard enteral alimentation. Crit Care Med, 1988;16(2):130-136.
21. Brinson RR, Curtis WD, Singh M. Diarrhea in the intensive care unit: the role of hypoalbuminemia and the response to a chemically defined diet (case reports and review of the literature). J Am Coll Nutr, 1987;6(6):517-523.
22. Mowatt-Larssen CA, Brown RO, Wojtysiak SL, et al. Comparison of tolerance and nutritional outcome between a peptide and a standard enteral formula in critically ill, hypoalbuminemic patients. JPEN J Parenter Enteral Nutr, 1992;16(1):20-24.
23. Viall C, Porcelli K, Teran JC, et al. A double-blind clinical trial comparing the gastrointestinal side effects of two enteral feeding formulas. JPEN J Parenter Enteral Nutr, 1990;14(3):265-269.
24. Heimburger DC, Geels VJ, Bilbrey J, et al. Effects of small-peptide and whole-protein enteral feedings on serum proteins and diarrhea in critically ill patients: a randomized trial. JPEN J Parenter Enteral Nutr, 1997;21(3):162-167.
25. Griffiths AM. Enteral nutrition in the management of Crohn's disease. JPEN J Parenter Enteral Nutr, 2005;29(4 Suppl):S108-S117.
26. O'Sullivan MA, O'Morain CA. Nutritional therapy in Crohn's disease. Inflamm Bowel Dis, 1998;4(1):45-53.
27. O'Sullivan M, O'Morain C. Nutritional Treatments in Inflammatory Bowel Disease. Curr Treat Options Gastroenterol, 2001; 4(3):207-213.
28. O'Sullivan M, O'Morain C. Nutritional Therapy in Inflammatory Bowel Disease. Curr Treat Options Gastroenterol, 2004;7(3): 191-198.
29. Griffiths AM, Ohlsson A, Sherman PM, et al. Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease. Gastroenterology, 1995;108(4):1056-1067.
30. Fernandez-Banares F, Cabre E, Esteve-Comas M, et al. How effective is enteral nutrition in inducing clinical remission in active Crohn's disease? A meta-analysis of the randomized clinical trials. JPEN J Parenter Enteral Nutr, 1995;19(5):356-364.
31. Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for inducing remission of Crohn's disease. Cochrane Database Syst Rev, 2001(3):CD000542.
32. Giaffer MH, North G, Holdsworth CD. Controlled trial of polymeric versus elemental diet in treatment of active Crohn's disease. Lancet, 1990;335(8693):816-819.
33. Ludvigsson JF, Krantz M, Bodin L, et al. Elemental versus polymeric enteral nutrition in paediatric Crohn's disease: a multicentre randomized controlled trial. Acta Paediatr, 2004; 93(3):327-335.
34. Verma S, Brown S, Kirkwood B, et al. Polymeric versus elemental diet as primary treatment in active Crohn's disease: a randomized, double-blind trial. Am J Gastroenterol, 2000;95(3):735-739.
35. Rigaud D, Cosnes J, Le Quintrec Y, et al. Controlled trial comparing two types of enteral nutrition in treatment of active Crohn's disease: elemental versus polymeric diet. Gut, 1991;32(12):1492-1497.
36. Gorard DA. Enteral nutrition in Crohn's disease: fat in the formula. Eur J Gastroenterol Hepatol, 2003;15(2):115-118.
37. Bamba T, Shimoyama T, Sasaki M, et al. Dietary fat attenuates the benefits of an elemental diet in active Crohn's disease: a randomized, controlled trial. Eur J Gastroenterol Hepatol, 2003;15(2):151-157.
38. Leiper K, Woolner J, Mullan MM, et al. A randomised controlled trial of high versus low long chain triglyceride whole protein feed in active Crohn's disease. Gut, 2001;49(6):790-794.
39. Gassull MA, Fernandez-Banares F, Cabre E, et al. Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial. Gut, 2002;51(2):164-168.
40. Sakurai T, Matsui T, Yao T, et al. Short-term efficacy of enteral nutrition in the treatment of active Crohn's disease: a randomized, controlled trial comparing nutrient formulas. JPEN J Parenter Enteral Nutr, 2002;26(2):98-103.
41. Ramsey BW, Farrell PM, Pencharz P. Nutritional assessment and management in cystic fibrosis: a consensus report. The Consensus Committee. Am J Clin Nutr, 1992;55(1):108-116.
42. Pelekanos JT, Holt TL, Ward LC, et al. Protein turnover in malnourished patients with cystic fibrosis: effects of elemental and nonelemental nutritional supplements. J Pediatr Gastroenterol Nutr, 1990;10(3):339-343.
43. Yoder AJ. Nutrition Support in Pancreatitis: Beyond Parenteral Nutrition. Practical Gastroenterology, 2003:19-30.
44. Kalfarentzos F, Kehagias J, Mead N, et al. Enteral nutrition is superior to parenteral nutrition in severe acute pancreatitis: results of a randomized prospective trial. Br J Surg, 1997;84(12):1665-1669.
45. McClave SA, Greene LM, Snider HL, et al. Comparison of the safety of early enteral vs parenteral nutrition in mild acute pancreatitis. JPEN J Parenter Enteral Nutr, 1997;21(1):14-20.
46. Windsor AC, Kanwar S, Li AG, et al. Compared with parenteral nutrition, enteral feeding attenuates the acute phase response and improves disease severity in acute pancreatitis. Gut, 1998;42(3): 431-435.
47. Pupelis G, Selga G, Austrums E, et al. Jejunal feeding, even when instituted late, improves outcomes in patients with severe pancreatitis and peritonitis. Nutrition, 2001;17(2):91-94.
48. Erstad BL. Enteral nutrition support in acute pancreatitis. Ann Pharmacother, 2000;34(4):514-521.
49. Powell JJ, Murchison JT, Fearon KC, et al. Randomized controlled trial of the effect of early enteral nutrition on markers of the inflammatory response in predicted severe acute pancreatitis. Br J Surg, 2000;87(10):1375-1381.
50. Yoder A, Parrish C, Yeaton P. A retrospective review of the course of patients with pancreatitis discharged on jejunal feedings. NCP, 2002;17:314-320.
51. O'Keefe SJ, Lee RB, Anderson FP, et al. Physiological effects of enteral and parenteral feeding on pancreaticobiliary secretion in humans. Am J Physiol Gastrointest Liver Physiol, 2003; 284(1):G27-G36.
52. Stanga Z, Giger U, Marx A, et al. Effect of jejunal long-term feeding in chronic pancreatitis. JPEN J Parenter Enteral Nutr, 2005;29(1):12-20.
53. McGough C, Baldwin C, Frost G, Andreyev HJ. Role of nutritional intervention in patients treated with radiotherapy for pelvic malignancy. Br J Cancer, 2004;90(12):2278-2287.
54. Suttmann U, Ockenga J, Schneider H, et al. Weight gain and increased concentrations of receptor proteins for tumor necrosis factor after patients with symptomatic HIV infection received fortified nutrition support. J Am Diet Assoc, 1996;96(6):565-569.
55. Pichard C, Sudre P, Karsegard V, et al. A randomized double-blind controlled study of 6 months of oral nutritional supplementation with arginine and omega-3 fatty acids in HIV-infected patients. Swiss HIV Cohort Study. Aids, 1998;12(1):53-63.
56. de Luis Roman DA, Bachiller P, Izaola O, et al. Nutritional treatment for acquired immunodeficiency virus infection using an enterotropic peptide-based formula enriched with n-3 fatty acids: a randomized prospective trial. Eur J Clin Nutr, 2001;55(12):1048-1052.
57. Gibert CL, Wheeler DA, Collins G, et al. Randomized, controlled trial of caloric supplements in HIV infection. Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr, 1999;22(3):253-259.
58. Hoh R, Pelfini A, Neese RA, et al. De novo lipogenesis predicts short-term body-composition response by bioelectrical impedance analysis to oral nutritional supplements in HIV-associated wasting. Am J Clin Nutr, 1998;68(1):154-163.
59. Rabeneck L, Palmer A, Knowles JB, et al. A randomized controlled trial evaluating nutrition counseling with or without oral supplementation in malnourished HIV-infected patients. J Am Diet Assoc, 1998;98(4):434-438.
60. Schwenk A, Steuck H, Kremer G. Oral supplements as adjunctive treatment to nutritional counseling in malnourished HIV-infected patients: randomized controlled trial. Clin Nutr, 1999; 18(6):371-374.
61. Micke P, Beeh KM, Schlaak JF, et al. Oral supplementation with whey proteins increases plasma glutathione levels of HIV-infected patients. Eur J Clin Invest, 2001;31(2):171-178.
62. McCray S, Parrish C. When chyle leaks: nutrition management options. Practical Gastroenterology, 2004;28(5):60-76.
63. Parrish CR, Krenitsky J, McCray S. University of Virginia Health System Nutrition Support Traineeship Syllabus, 2003. Available at: http://www. healthsystem.virginia.edu/internet/dietitian/dh/ traineeship.cfm.